1. Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives
   Palmiro Poltronieri et al, 2021, Cells CrossRef
2. Centella asiatica Alters Metabolic Pathways Associated With Alzheimer’s Disease in the 5xFAD Mouse Model of ß-Amyloid Accumulation
   Alex B. Speers et al, 2021, Front. Pharmacol. CrossRef
3. Age-Dependent Decline of NAD+—Universal Truth or Confounded Consensus?
   Augusto Peluso et al, 2021, Nutrients CrossRef
4. Astrocyte-derived lactate/NADH alters methamphetamine-induced memory consolidation and retrieval by regulating neuronal synaptic plasticity in the dorsal hippocampus
   Xu Tan et al, 2022, Brain Struct Funct CrossRef
5. Nicotinamide as potential biomarker for Alzheimer’s disease: A translational study based on metabolomics
   María C. Dalmasso et al, 2023, Front. Mol. Biosci. CrossRef
6. Danggui Shaoyao San: comprehensive modulation of the microbiota-gut-brain axis for attenuating Alzheimer’s disease-related pathology
   Jiawei He et al, 2024, Front. Pharmacol. CrossRef
7. The interaction between microglial dysfunction and mitochondrial impairment in Alzheimer’s disease
   Qiudan Luo et al, 2023 CrossRef
8. Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function
   Mengzhu Su et al, 2024, Front. Cell Dev. Biol. CrossRef